Correlation Between Knight Therapeutics and Alterola Biotech
Can any of the company-specific risk be diversified away by investing in both Knight Therapeutics and Alterola Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Knight Therapeutics and Alterola Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Knight Therapeutics and Alterola Biotech, you can compare the effects of market volatilities on Knight Therapeutics and Alterola Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Knight Therapeutics with a short position of Alterola Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Knight Therapeutics and Alterola Biotech.
Diversification Opportunities for Knight Therapeutics and Alterola Biotech
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Knight and Alterola is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Knight Therapeutics and Alterola Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterola Biotech and Knight Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Knight Therapeutics are associated (or correlated) with Alterola Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterola Biotech has no effect on the direction of Knight Therapeutics i.e., Knight Therapeutics and Alterola Biotech go up and down completely randomly.
Pair Corralation between Knight Therapeutics and Alterola Biotech
Assuming the 90 days horizon Knight Therapeutics is expected to under-perform the Alterola Biotech. But the pink sheet apears to be less risky and, when comparing its historical volatility, Knight Therapeutics is 7.95 times less risky than Alterola Biotech. The pink sheet trades about -0.17 of its potential returns per unit of risk. The Alterola Biotech is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.53 in Alterola Biotech on September 1, 2024 and sell it today you would lose (0.03) from holding Alterola Biotech or give up 5.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Knight Therapeutics vs. Alterola Biotech
Performance |
| Timeline |
| Knight Therapeutics |
| Alterola Biotech |
Knight Therapeutics and Alterola Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Knight Therapeutics and Alterola Biotech
The main advantage of trading using opposite Knight Therapeutics and Alterola Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Knight Therapeutics position performs unexpectedly, Alterola Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterola Biotech will offset losses from the drop in Alterola Biotech's long position.| Knight Therapeutics vs. Brainsway | Knight Therapeutics vs. Venus Concept | Knight Therapeutics vs. Tactile Systems Technology | Knight Therapeutics vs. Icecure Medical |
| Alterola Biotech vs. Holloman Energy Corp | Alterola Biotech vs. cbdMD Inc | Alterola Biotech vs. Evolus Inc | Alterola Biotech vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |